Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Enterprise value

Enterprise value at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc. INDV
$4.05B+242%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.27B-4.1%
Avanos Medical logo
Avanos MedicalAVNS
$724.37M+3.0%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$1.18B-3.4%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$2.83B+62.3%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$588.13M+55.1%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

$1.1Bmarket cap+$5.2Mtotal debt−$289.6Mcash and equivalents=$765.76M

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s enterprise value?
Collegium Pharmaceutical, Inc. (COLL) reported enterprise value of $765.76M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s enterprise value changed year-over-year?
Collegium Pharmaceutical, Inc.'s enterprise value decreased by 9.8% year-over-year, from $848.54M to $765.76M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s enterprise value has grown at a 18.2% compound annual growth rate (CAGR), from $527.79M to $1.22B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.